We also examined the effect of host factor, tissue compartment, and treatment timing in the protective capacity of SLR14, and we found that the protective efficacy of SLR14 depends on intact IFNAR signaling and that early SLR14 administration provided superior protection, while treatment as late as 48 h after infection still afforded partial protection. This evidence concerns the gene IFNAR1 and infection.